A doctor script for naming your insurance at the first visit

Doctors rarely ask what kind of insurance you have when the subject turns to depression. The front desk knows. The billing office knows. But the person deciding where to refer you may not have it in mind at all. That gap can send you toward a clinic that will never take your plan.

The fix is a single sentence, said early. This article gives you that sentence and a few more, organized by the kind of coverage you have, so the referral you leave with is one you can actually use.

Why the kind of coverage matters so much

Our summer poll asked 443 adults across ten Midwest states about their insurance and what matters most in choosing a provider. Two things stood out.

First, coverage was the leading consideration by far. More than four in five respondents, 85 percent, put insurance on their short list of two.

Second, the coverage people hold is split more evenly than many clinics assume. Among respondents, 39 percent had commercial coverage and 37 percent Medicaid; 23 percent reported Medicare, 9 percent reported none, and 5 percent reported TRICARE, with some holding more than one. These numbers are final.

Put those together and the lesson for your appointment is clear. What your plan is determines which doors are open. Say it out loud.

The opening line, for everyone

Whatever you carry, begin with the problem, then the plan.

"My depression has not improved on the medications I have tried. I want to talk about other options. Before we get into specifics, I should tell you I have [plan name], and whether something is covered is going to matter a lot for me."

That tells your doctor three things at once: how you are doing, that you are open to next steps, and what constraint to plan around. In our poll, 65 percent rated coverage as deciding or big for trying a newer treatment. You are not being difficult. You are being typical.

If you have Medicaid

"I am on Medicaid through [managed care plan name]. If you think I might be a candidate for something like esketamine, could you refer me to a place that accepts my plan? And would you be able to document my medication history for a prior authorization if it is needed?"

Why this helps: many specialty practices limit how many Medicaid patients they see, or do not participate at all. Naming your specific managed care plan, not just "Medicaid," lets your doctor's staff check the right network. You might also ask:

"Is there a community mental health center nearby that could do an evaluation?"

If you have commercial insurance

"I have [plan name] through [employer or marketplace]. I think my mental health benefits may go through a separate company. If you refer me somewhere, could your office check that they are in network for my behavioral health coverage specifically?"

Why this helps: employer plans frequently hand mental health care to a separate vendor with its own network. A clinic that is in network for your medical coverage may be out of network for behavioral health, and that surprise can be expensive.

If you have Medicare

"My coverage is [original Medicare, or an Advantage plan named ___]. If esketamine comes up, could you point me to a site that bills Medicare for it regularly?"

Why this helps: drug-plus-observation care bills in more than one way, and experienced sites know how.

If you have TRICARE

"I have TRICARE. Do I need a referral from you or my primary care manager for this, and can you send me to someone in the TRICARE network?"

Why this helps: TRICARE often requires referrals for specialty care, and missing that step can delay everything.

If you have no insurance

"I do not have insurance right now. What would you recommend that I can realistically afford? And is it possible I qualify for Medicaid?"

Why this helps: it moves the conversation from the ideal plan to the workable one, and it opens the door to coverage you may not know you are eligible for. Ask any referral site for written self-pay pricing before you commit.

The treatment question, asked honestly

Once coverage is on the table, you can ask about the treatment itself. Keep it open-ended so your doctor can say no if no is the right answer.

"I read that Spravato, the esketamine spray, is meant for depression that other medicines have not fixed. Is that my situation? If not, what would you try?"

The FDA approved esketamine for hard-to-treat depression. Certified clinics give it, observe you for two hours or more per dose, and require that someone else drive. Brain Recovery Centers explains how esketamine is billed and what it may cost if you want the numbers before your visit. It is not the right fit for everyone, and your doctor may recommend another step first. That is a medical judgment you should welcome.

The doctor's role in all this

People in our survey were unambiguous about who they trust. In our poll, a doctor's recommendation carried the most weight, with 74 percent, nearly three in four, against 18 percent for friends or family and 2 percent for ads, and 56 percent would start with a primary doctor.

Your doctor also writes the notes a prior authorization depends on.

Before you leave

• Confirm the name of any site you are being referred to.
• Ask who will check whether that site takes your plan.
• Ask who starts the prior authorization, if one is needed.
• Ask what to do if the referral falls through.

Nothing here is medical advice. Outcomes are never certain, and your clinician decides which option fits.

Should thoughts of ending your life come up, say so to your doctor, or use 988 by call or text this minute. Counselors at the Suicide and Crisis Lifeline are available every hour and never ask about coverage.

Methodology

Our numbers trace to Pollfish's consumer panel, where study 395586438 ran until June 23, 2026, ending at 443 completes from people aged 18 through 64 in Missouri, Minnesota, Kansas, Illinois, Nebraska, Iowa, Oklahoma, Wisconsin, Ohio and Indiana. Coverage type accepted multiple answers. All percentages describe the full sample and have passed validation. This article's publisher ordered and paid for the study.